Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05248581 · ClinicalTrials.gov registry record
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
A clinical trial of Colorectal Cancer Metastatic, sponsored by University of Rochester.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT05248581: Recruiting study of Colorectal Cancer Metastatic, sponsored by University of Rochester.
NCT05248581 is a study of Colorectal Cancer Metastatic that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 25 participants, below the 204-participant average among 18 other Colorectal Cancer Metastatic trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05248581, a study of Colorectal Cancer Metastatic, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation.
Primary Outcome
RFS proportions to be calculated at 1, 3, and 5 years with Kaplan Meier analysis
Conditions Studied
Interventions
- PROCEDURE Liver transplantation
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-08-16 |
| Est. Completion | 2027-08-01 |
What NCT05248581 shows while recruiting
NCT05248581 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 204-participant average among 18 other Colorectal Cancer Metastatic trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Colorectal Cancer Metastatic appearing as the primary indexed condition, and to 1 intervention - of which Liver transplantation is the first listed.
NCT05248581 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05248581 about?
NCT05248581 is a clinical study titled "Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases". The goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation.
What is the current status of trial NCT05248581?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2019-08-16. Estimated completion is 2027-08-01.
What conditions does trial NCT05248581 study?
This clinical trial studies the following conditions: Colorectal Cancer Metastatic.
What interventions are being tested in trial NCT05248581?
The interventions under investigation include: Liver transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT05248581?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05248581 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Metastatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05248581's enrollment target sits among peer trials
25 13th of 18 higher than 6 of 18 other Colorectal Cancer Metastatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Metastatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
RECRUITING · Phase 2
-
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
RECRUITING · Early Phase 1
-
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
RECRUITING
-
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
RECRUITING · Early Phase 1
-
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
RECRUITING · Phase 2
-
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI